Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.9, Iss.4, 2013-04, pp. : 391-401

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging treatments for chronic constipation

By Gudsoorkar Vineet S Quigley Eamonn MM

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 3, 2013-09 ,pp. : 365-373

Informa Healthcare

Access to resources Recommend Favorite

Development of Biosimilars—Pharmacokinetic and Pharmacodynamic Considerations

By Wang Yow-Ming Chow Andrew

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 1, 2010-01 ,pp. : 46-61

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamic considerations for NMDA receptor antagonists in the treatment of chronic neuropathic pain

By Niesters Marieke Dahan Albert

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1409-1417

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic and Pharmacodynamic Considerations in the Development of Therapeutic Proteins

By Mahmood Iftekhar Green Martin D.

Clinical Pharmacokinetics, Vol. 44, Iss. 4, 2005-01 ,pp. : 331-347

Adis International

Access to resources Recommend Favorite

Penetration of Antibacterials into Bone: Pharmacokinetic, Pharmacodynamic and Bioanalytical Considerations

By Landersdorfer Cornelia B.

Clinical Pharmacokinetics, Vol. 48, Iss. 2, 2009-01 ,pp. : 89-124

Adis International

Access to resources Recommend Favorite